Skip to search formSkip to main contentSkip to account menu

pagoclone

Known as: 1H-Isoindol-1-One, 2-(7-Chloro-1,8-Naphthyridin-2-yl)-2,3-Dihydro-3-(5-Methyl-2-Oxohexyl)-, (+)-, 2-(7-chloro-1.8-naphthyridin-2-yl)-2,3-dihydro-3-(5-methyl-2-oxohexyl)-1H-isoindol-1-one 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

IsoindolesNaphthyridines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Dérivé 2,3-dihydro-isoindol-1-one et composition le comprenant
La presente invention concerne une composition pharmaceutique pour le traitement, le soulagement ou la prevention de maladies… 
2010
2010
Comments on article by Maguire et al: pagoclone trial: questionable findings for stuttering treatment.
2010
2010
Gateways to clinical trials.
[¹¹C]RAC; (18)F-Fluoromisonidazole; 89-12; 9-[¹⁸F]Fluoropropyl-(+)-dihydrotetrabenazine; Adalimumab, Adecatumumab, ADMVA, ADXS-11… 
2007
2007
Gateways to clinical trials.
Agomelatine, AGRO-100, AIDSVAX gp120 B/E, alfimeprase, aliskiren fumarate, ALVAC vCP1452, alvocidib hydrochloride, ambrisentan… 
2006
2006
Pagoclone pronounced effective for the treatment of stuttering
  • 2006
  • Corpus ID: 195123731
2004
2004
Gateways to clinical trials.
Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the… 
Review
2003
Review
2003
Pagoclone Indevus.
Pagoclone is a cyclopyrrolone GABAA receptor modulator under development by Indevus for the potential treatment of panic and… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)